Single-dose oral cholera vaccine completes phase 1 trial with promising results

A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.

source https://medicalxpress.com/news/2026-01-dose-oral-cholera-vaccine-phase.html